Processa Pharmaceuticals Stock Today
| PCSA Stock | USD 1.56 0.10 6.02% |
Performance0 of 100
| Odds Of DistressOver 85
|
Processa Pharmaceuticals is trading at 1.56 as of the 18th of April 2024, a -6.02 percent decrease since the beginning of the trading day. The stock's open price was 1.66. Processa Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Processa Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of September 2022 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 10th of October 2017 | Category Healthcare | Classification Health Care |
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. The company was incorporated in 2011 and is based in Hanover, Maryland. The company has 2.86 M outstanding shares of which 35.81 K shares are at this time shorted by private and institutional investors with about 0.44 trading days to cover. More on Processa Pharmaceuticals
Moving against Processa Stock
| 0.7 | EWTX | Edgewise Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.57 | JSPRW | Jasper Therapeutics | PairCorr |
| 0.47 | EOLS | Evolus Inc Financial Report 14th of May 2024 | PairCorr |
| 0.44 | INZY | Inozyme PharmaInc Financial Report 14th of May 2024 | PairCorr |
| 0.42 | IOVA | Iovance Biotherapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.42 | MRSN | Mersana Therapeutics Downward Rally | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Processa Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Processa Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Processa Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | David Young | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Processa Pharmaceuticals report their recommendations after researching Processa Pharmaceuticals' financial statements, talking to executives and customers, or listening in on Processa Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Processa Pharmaceuticals. The Processa consensus assessment is calculated by taking the average forecast from all of the analysts covering Processa Pharmaceuticals. | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Processa Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Processa Pharmaceuticals is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Processa Pharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
Processa Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Processa Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Processa Pharmaceuticals' financial leverage. It provides some insight into what part of Processa Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Processa Pharmaceuticals (PCSA) is traded on NASDAQ Exchange in USA. It is located in 7380 Coca Cola Drive, Hanover, MD, United States, 21076 and employs 13 people. Processa Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.4 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Processa Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Processa Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Processa Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry. The entity has 2.86 M outstanding shares of which 35.81 K shares are at this time shorted by private and institutional investors with about 0.44 trading days to cover.
Processa Pharmaceuticals currently holds about 12.06 M in cash with (8.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76.
Check Processa Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationProcessa Pharmaceuticals holds 11.27 pct. of its outstanding shares held by insiders and 1.98 pct. owned by third-party entities.
Check Processa Ownership Details
Processa Stock Price Odds Analysis
What are Processa Pharmaceuticals' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Processa Pharmaceuticals jumping above the current price in 90 days from now is about 88.59%. The Processa Pharmaceuticals probability density function shows the probability of Processa Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 6.7442 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Processa Pharmaceuticals will likely underperform. Additionally, processa Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Processa Pharmaceuticals to move above the current price in 90 days from now is about 88.59 (This Processa Pharmaceuticals probability density function shows the probability of Processa Stock to fall within a particular range of prices over 90 days) .
Processa Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Processa Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Processa Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Processa Pharmaceuticals' value.| Instituion | Recorded On | Shares | |
| Hrt Financial Llc | 2023-12-31 | 11.7 K | |
| Wells Fargo & Co | 2023-12-31 | 3.2 K | |
| Hanson Mcclain Inc | 2023-12-31 | 1.7 K | |
| Tower Research Capital Llc | 2023-12-31 | 1.2 K | |
| Blackrock Inc | 2023-12-31 | 293 | |
| Susquehanna International Group, Llp | 2023-09-30 | 0.0 | |
| Mirador Capital Partners Lp | 2023-12-31 | 0.0 | |
| Millennium Management Llc | 2023-12-31 | 0.0 | |
| Verdence Capital Advisors Llc | 2023-09-30 | 0.0 | |
| Vanguard Group Inc | 2023-12-31 | 234.7 K | |
| Citadel Advisors Llc | 2023-09-30 | 166.2 K |
Processa Pharmaceuticals Historical Income Statement
Processa Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting Processa's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Processa Pharmaceuticals revenue and expense. Processa Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Processa Pharmaceuticals' Interest Expense is projected to decrease significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 5.9 M, whereas Gross Profit is forecasted to decline to (233.10). View More FundamentalsProcessa Stock Against Markets
Picking the right benchmark for Processa Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Processa Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Processa Pharmaceuticals is critical whether you are bullish or bearish towards Processa Pharmaceuticals at a given time. Please also check how Processa Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Processa Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Processa Pharmaceuticals Corporate Executives
Elected by the shareholders, the Processa Pharmaceuticals' board of directors comprises two types of representatives: Processa Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Processa. The board's role is to monitor Processa Pharmaceuticals' management team and ensure that shareholders' interests are well served. Processa Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Processa Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Wendy Guy | Founder, Chief Administrative Officer | Profile | |
| Sian Bigora | Chief Development Officer, Founder | Profile |
How to buy Processa Stock?
Before investing in Processa Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Processa Pharmaceuticals. To buy Processa Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Processa Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Processa Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Processa Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Processa Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Processa Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Processa Stock please use our How to Invest in Processa Pharmaceuticals guide.
Already Invested in Processa Pharmaceuticals?
The danger of trading Processa Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Processa Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Processa Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Processa Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Processa Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Processa Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Processa Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Processa Pharmaceuticals Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Processa Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For information on how to trade Processa Stock refer to our How to Trade Processa Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Processa Stock analysis
When running Processa Pharmaceuticals' price analysis, check to measure Processa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Processa Pharmaceuticals is operating at the current time. Most of Processa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Processa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Processa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Processa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Processa Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Processa Pharmaceuticals. If investors know Processa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Processa Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.48) | Return On Assets (0.99) | Return On Equity (1.79) |
The market value of Processa Pharmaceuticals is measured differently than its book value, which is the value of Processa that is recorded on the company's balance sheet. Investors also form their own opinion of Processa Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Processa Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Processa Pharmaceuticals' market value can be influenced by many factors that don't directly affect Processa Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Processa Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Processa Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Processa Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.